Fresh from a successful USA Pro Challenge, Team Novo Nordisk, the only all-diabetes professional men’s team, is heading to the United Kingdom for the Aviva Tour of Britain, which will pass through Northumberland on Wednesday.
The team is eager to build upon recent results and it will be the second time the team has participated in the eight-day stage race.
The event begins in Wales on Sunday, September 6, before finishing in London on Sunday, September 13. It will enter Northumberland from the Scottish Borders on Wednesday, September 9, during Stage Four. It will head along a route from Wooler to Alnwick then down the Northumberland coastline, via Amble and Cresswell, to finish that day in Blyth.
The race will restart the following morning from Prudhoe and will follow Hadrian’s Wall, heading across the Pennines into Cumbria before ending in a summit finish on Hartside Fell – one of the key stages of the race.
Leading Team Novo Nordisk will be Javier Megias, who took second on a stage of the recent USA Pro Challenge.
“Javier just earned the team its best result at a 2.HC race at the USA Pro Challenge. He almost took the win on Stage Six and getting caught at the line has only tripled his desire to get a win,” said Senior Vice President of Athletics Vassili Davidenko.
“In addition to Javier, we are bringing our most experienced riders with a mix of sprinting and climbing talent. We will fight every day and hopefully garner more results against the impressive field.
“This year marks the second time Team Novo Nordisk is racing at the Tour of Britain, so we are more familiar with the smaller roads and how the race unfolds because of smaller team sizes,” Davidenko continued.
“We will use this experience in our daily race strategy and will try to be active every single day.”
All of Team Novo Nordisk’s riders have type 1 diabetics. They have recently raced in the Tour of Denmark, USA Pro Challenge and Tour of California, and will be returning for the second attempt at the Aviva Tour of Britain, having made their debut in 2014.
Team Novo Nordisk’s six-man roster features Kevin De Mesmaeker (BEL), Joonas Henttala (FIN), David Lozano (ESP), Javier Megias (ESP), Andrea Peron (ITA) and Charles Planet (FRA). All the riders except for De Mesmaeker competed in last year’s race.
“I have been excited about returning to the Tour of Britain all season because the race is so well organised with phenomenal crowds and a beautiful course,” Henttala said.
“The spectators truly make this race special. I’m looking forward to the reduced team sizes because it means the race is less controlled and increases the possibility that a breakaway can make it to the finish.”
The Team Novo Nordisk line-up joins the likes of Mark Cavendish, Sir Bradley Wiggins, Edvald Boasson Hagen, Gerald Ciolek, Andre Greipel and 2014 overall Tour of Britain winner Dylan Van Baarle as already confirmed for the 2015 Aviva Tour of Britain.
The Aviva Tour of Britain is British Cycling’s premier road cycling event giving cycling fans the opportunity to see the world’s best teams and riders competing on their doorstep.